Racial and Ethnic Differences in the Real-World Clinical Outcomes of IDH1 and IDH2 Inhibitors in Acute Myeloid Leukemia
Research Grant
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
University of North Carolina - Chapel Hill
Start Date
September 1, 2024
End Date
August 31, 2026
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
University of North Carolina - Chapel Hill
Start Date
September 1, 2024
End Date
August 31, 2026